Literature DB >> 29524030

Vitreous IL-8 and VEGF levels in diabetic macular edema with or without subretinal fluid.

Fatih Yenihayat1, Berna Özkan2, Murat Kasap3, V Levent Karabaş4, Nil Güzel3, Gürler Akpınar3, Dilara Pirhan4.   

Abstract

PURPOSE: To determine the cytokine levels in vitreous samples of diabetic macular edema (DME) patients in comparison with nondiabetic patients, and to evaluate the effect of subretinal fluid on the cytokine levels of vitreous samples.
METHODS: In this prospective case-control study, 11 eyes of 11 patients with DME and subretinal fluid, 11 eyes of 11 patients with DME without subretinal fluid, and 14 eyes of 14 patients who had undergone vitreoretinal surgery for the epiretinal membrane or a macular hole (control group) were evaluated. The blood glycated hemoglobin (HbA1c) level, vitreous vascular endothelial growth factor (VEGF), and interleukin-8 (IL-8) levels were determined.
RESULTS: The vitreous VEGF level of patients in DME groups was significantly higher than the control group (p < 0.001) without significant difference between DME patients with and without subretinal fluid (p = 0.796). The vitreous IL-8 level of DME patients with subretinal fluid was significantly higher than both control (p = 0.002) and DME without subretinal fluid groups (p = 0.019). The blood HbA1c level was significantly higher in DME group with subretinal fluid than those without subretinal fluid (8.7 ± 1.32 and 7.1 ± 1.13%, respectively, p = 0.010). The only significant correlation was between vitreous VEGF level and blood HbA1c level in DME patients without subretinal fluid (r = 0.813, p = 0.002).
CONCLUSIONS: IL-8 level in vitreous samples was higher in DME patients with subretinal fluid than those without subretinal fluid, suggesting that inflammation is an important factor in the progression of DME leading to the subretinal fluid formation in diabetic patients.

Entities:  

Keywords:  Cystoid macular edema; Diabetes; Interleukin-8; Intraocular cytokines; Subretinal fluid

Mesh:

Substances:

Year:  2018        PMID: 29524030     DOI: 10.1007/s10792-018-0874-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1α-VEGF pathway.

Authors:  Yi-Hsun Huang; Cheng-Hsiang Kuo; I-Chen Peng; Yi-Sheng Chang; Sung-Huei Tseng; Edward M Conway; Hua-Lin Wu
Journal:  Cell Mol Life Sci       Date:  2021-10-27       Impact factor: 9.261

2.  OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.

Authors:  Jingxin Zhou; Siyuan Song; Yi Zhang; Kai Jin; Juan Ye
Journal:  Ophthalmol Ther       Date:  2022-09-27

3.  Systemic and vitreous biomarkers - new insights in diabetic retinopathy.

Authors:  Bernardete Pessoa; João Heitor; Constança Coelho; Magdalena Leander; Pedro Menéres; João Figueira; Angelina Meireles; Melo Beirão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-24       Impact factor: 3.535

Review 4.  Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.

Authors:  Hannah Youngblood; Rebekah Robinson; Ashok Sharma; Shruti Sharma
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

5.  Differences in activation of intracellular signaling in primary human retinal endothelial cells between isoforms of VEGFA 165.

Authors:  Wendelin Dailey; Roberto Shunemann; Fang Yang; Megan Moore; Austen Knapp; Peter Chen; Mrinalini Deshpande; Brandon Metcalf; Quentin Tompkins; Alvaro E Guzman; Jennifer Felisky; Kenneth P Mitton
Journal:  Mol Vis       Date:  2021-04-28       Impact factor: 2.367

6.  Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice.

Authors:  Rajya L Gurung; Liesel M FitzGerald; Bennet J McComish; Alex W Hewitt; Nitin Verma; Kathryn P Burdon
Journal:  BMJ Open Ophthalmol       Date:  2021-05-03

7.  Aqueous Level of ANGPTL4 Correlates with the OCTA Metrics of Diabetic Macular Edema in NPDR.

Authors:  Qing Xu; Chaoju Gong; Lei Qiao; Ruifang Feng; Haiyang Liu; Yalu Liu; Sujuan Ji; Yipeng Zhang; Shuang Wu; Suyan Li
Journal:  J Diabetes Res       Date:  2022-01-19       Impact factor: 4.011

8.  Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy.

Authors:  Ricardo Lamy; Suzette Farber-Katz; Franklin Vives; Gulesi Ayanoglu; Tong Zhao; Yi Chen; Sawarin Laotaweerungsawat; Dahui Ma; Audrey Phone; Catherine Psaras; Nina Xiaoyan Li; Santosh Sutradhar; Paul E Carrington; Jay M Stewart
Journal:  Transl Vis Sci Technol       Date:  2020-09-02       Impact factor: 3.283

9.  Characteristics of diabetic macular edema patients with serous retinal detachment.

Authors:  Hyung Bin Hwang; Donghyun Jee; Jin-Woo Kwon
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  Aqueous humor analyses of diabetic macular edema patients with subretinal fluid.

Authors:  Jin-Woo Kwon; Byungjin Kim; Donghyun Jee; Yang Kyung Cho
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.